INTRODUCTION {#S1}
============

The serious metabolic complications closely associated with obesity emphasize the urgency to develop counteracting strategies. It has recently been reported that beige-like thermogenic adipocytes are present in human adults^[@R1]--[@R4]^ and that the activation of these thermogenic fat cells increases energy expenditure and improves metabolic health in humans^[@R5]--[@R9]^. Whereas the regulation of white and classical brown fat cells has been investigated for decades, many aspects of the beige adipocyte function are still yet to be elucidated.

Previous studies of the regulation of thermogenic fat cells *in vivo* have mainly been focused on signaling through the β-adrenergic pathway^[@R10]^. Here we demonstrate that CHRNA2, a subunit of the nicotinic acetylcholine receptor family, is upregulated during beiging and specifically functions in beige fat cells from subcutaneous adipose depots. The nAChRs belong to a large superfamily of ligand-gated ion channels that are expressed throughout both the central and the peripheral nervous systems, as well as in non-neuronal cell populations^[@R11],[@R12]^. At an individual-cell level resolution, we observed that CHRNA2-mediated signaling specifically occurs in *Ucp1*-expressing beige fat cells within subcutaneous culture, but not in either white or brown fat cells. Calcium imaging assays further revealed that primary fat cells from the human subcutaneous depot but not those from the perirenal depot respond to CHRNA2 agonist stimulation, suggesting that this beige-selective response is conserved in humans. We identified acetylcholine-producing immune cells within the subcutaneous fat depot that communicate with beige fat cells via CHRNA2 through paracrine signaling. Additionally, *Chrna2* KO mice have a compromised response to cold specifically in beige fat and impaired metabolic homeostasis upon dietary challenges. Our results identify CHRNA2 as a functional beige-selective marker and suggest that this immune-adipose interaction through acetylcholine and CHRNA2 may lead to novel druggable targets to treat human obesity and the metabolic syndrome.

RESULTS {#S2}
=======

*Chrna2* is induced in subcutaneous adipocytes during beiging {#S3}
-------------------------------------------------------------

Rosiglitazone (Rosi), a thiazolidinedione (TZD) that acts as a PPARγ agonist, has been shown to induce the activation of "browning" *in vitro* and *in vivo*^[@R13]--[@R15]^. Thus, in order to investigate which signaling pathways activate beige adipocytes, we performed a microarray analysis with RNA samples from fully differentiated primary preadipocytes isolated from the murine inguinal subcutaneous fat depot (one where beige adipocytes are most abundant) followed by treatment *in vitro* with Rosi or a vehicle control. As expected, the thermogenic marker *Ucp1* was induced in the Rosi-treated samples. It is of note that *Chrna2*, one of the subunits of nAChRs was greatly induced with Rosi treatment in these fat cultures ([Fig. 1a](#F1){ref-type="fig"}). The *Chrna2* induction was confirmed by quantitative PCR (qPCR) performed on primary inguinal fat cells from multiple strains of inbred mice ([Fig. 1a](#F1){ref-type="fig"} and [Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}). Further analyses revealed that *Chrna2* expresses at significant levels in subcutaneous adipocytes and among all nAChR subunits, it is the only one whose expression level was regulated during Rosi-induced beiging ([Fig. 1b](#F1){ref-type="fig"} and [Supplementary Fig. 1b,c](#SD1){ref-type="supplementary-material"}).

A spectrum of signaling pathways and molecules have been reported to activate adaptive thermogenesis in adipocytes^[@R10]^. *Chrna2* expression was induced by many of these beiging stimuli, including norepinephrine, isoproterenol (Iso, a pan adrenergic agonist), CL-316,243 (CL, a β3-adrenergic specific agonist), dibutyryl-cAMP (cAMP, a cyclic nucleotide derivative that mimics endogenous cAMP), or triiodothyronine (T3, a thyroid hormone that has long been known to play a role in regulating thermogenesis^[@R10]^) ([Fig. 1c](#F1){ref-type="fig"}). Furthermore, *Chrna2* mRNA expression was induced during *in vivo* "beiging" in the inguinal fat after cold exposure (CE) or Rosi treatment ([Fig. 1d](#F1){ref-type="fig"} and [Supplementary Fig. 1d](#SD1){ref-type="supplementary-material"}). Conversely, *Chrna2* expression was significantly lower in inguinal fat of obese mice compared to that of lean mice ([Supplementary Fig. 1e](#SD1){ref-type="supplementary-material"}). It has been previously reported that differentiated human adipose precursors from subcutaneous fat respond to thermogenic stimulants^[@R16],[@R17]^, suggesting that besides their presence in the supraclavicular region, thermogenic adipocytes may also exist in the human subcutaneous depot. Similar to their murine counterparts, induction of *CHRNA2* expression was observed in differentiated primary adipose stromal cells (ASC) isolated from the human subcutaneous depot upon treatments with Rosi and Iso ([Fig. 1e](#F1){ref-type="fig"}), indicating that this observed *Chrna2* induction is relevant to human physiology.

Mechanistic studies revealed that *Chrna2* expression was markedly induced during the adipogenesis of inguinal preadipocytes alongside with adipogenic and thermogenic markers, such as *Pparg* and *Ucp1*, under chronic Rosi treatment ([Fig. 1f](#F1){ref-type="fig"}). A promoter fragment that contains 1.1kb of the 5′ flanking region of murine *Chrna2* was activated (induced by 4-fold) by the expression of PPARγ ([Fig. 1g](#F1){ref-type="fig"}). Chromatin ImmunoPrecipitation (ChIP) assays confirmed that PPARγ recruitment was enriched on the promoter region of *Chrna2* between −164bp and −151bp to stimulate *Chrna2* transcription in inguinal adipocytes ([Fig. 1h](#F1){ref-type="fig"}). Together these data suggest that *Chrna2* was regulated by PPARγ as a direct target during beige adipogenesis ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}).

CHRNA2 signaling is beige adipocyte-selective {#S4}
---------------------------------------------

To directly examine whether CHRNA2-containing ion channels are functional in fat cells, particularly beige adipocytes as *Chrna2* is inducible during the beiging process, we generated "beige-fat-reporter mice" by crossing *Ucp1*-CRE transgenic mice^[@R18]^ and Ai14 reporter mice^[@R19]^ in which *Ucp1*-expressing adipocytes are labeled with red fluorescent protein (RFP). ([Fig. 2a](#F2){ref-type="fig"}). We validated the presence of RFP+ cells through analysis of *Rfp* (*tdTomato*) expression in differentiated primary inguinal preadipocytes as well as in the inguinal adipose tissue of *Ucp1*-CRE-RFP mice ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). Both acetylcholine (Ach) and nicotine (Nic), agonists of nAChR channels, induced an increase in intracellular calcium in the RFP-labeled beige fat cells ([Fig. 2b](#F2){ref-type="fig"} and [Supplementary Fig. 4b](#SD1){ref-type="supplementary-material"}). This agonist-induced calcium uptake in RFP+ beige adipocytes was further increased in the presence of Rosi, consistent with the notion that CHRNA2 forms a functional ion channel in activated beige adipocytes. ([Supplementary Fig. 4g](#SD1){ref-type="supplementary-material"}). However, no response to either agonist was detected in RFP-negative white adipocytes ([Fig. 2b](#F2){ref-type="fig"} and [Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}). We did not observe any response to acetylcholine or nicotine in the RFP+ brown fat cells isolated from the interscapular depot of the same mice ([Fig. 2c](#F2){ref-type="fig"} and [Supplementary Fig. 4c](#SD1){ref-type="supplementary-material"}). This strongly suggests that the response to CHRNA2 agonists is beige fat-specific. No cell from the *Chrna2* KO inguinal fat cultures responded to agonist stimulation, suggesting that the observed response is CHRNA2-dependent ([Fig. 2d](#F2){ref-type="fig"} and [Supplementary Fig. 4d](#SD1){ref-type="supplementary-material"}, [5a](#F5){ref-type="fig"}). A similar response to nicotine and acetylcholine was observed via a calcium imaging assay on primary human subcutaneous fat cultures ([Fig. 2e, f](#F2){ref-type="fig"} and [Supplementary Fig. 4e](#SD1){ref-type="supplementary-material"}), and could be blocked by *CHRNA2* knockdown in these human subcutaneous adipose cultures ([Supplementary Fig. 5b](#SD1){ref-type="supplementary-material"}), indicating that beige-like thermogenic fat cells exist in human subcutaneous depots and can be functionally regulated through CHRNA2 signaling. We further tested CHRNA2 signaling in differentiated preadipocytes isolated from human perirenal fat, a depot that has been reported to contain thermogenic adipocytes more similar to murine classical brown fat^[@R20]--[@R22]^. Human perirenal adipocytes, while perfectly responsive to other stimuli (e.g. menthol^[@R23]^), showed no response to either acetylcholine or nicotine ([Fig. 2g](#F2){ref-type="fig"} and [Supplementary Fig. 4f](#SD1){ref-type="supplementary-material"}, [5c](#F5){ref-type="fig"}). Since activation of CHRNA2 was detected within the human subcutaneous but not perirenal fat culture, our results provide functional proof for the distinction of these two types of thermogenic fat in adult humans.

Since the calcium imaging assay indicated that the CHRNA2-containing ion channel is functional in beige adipocytes, we next investigated how CHRNA2 signaling is mediated in differentiated primary inguinal preadipocytes. Thermogenic markers *Ucp1, Dio2* and *Cox8b* were induced with nicotine treatment compared to control ([Fig. 2h](#F2){ref-type="fig"}). It is worth noting that the *Chrna2* receptor itself was also induced upon nicotine treatment. This is consistent with our previous data showing that *Chrna2* was induced during the activation of beige fat cells ([Fig. 1](#F1){ref-type="fig"}). We observed a clear elevation of cAMP, a second messenger molecule to thermogenic stimuli, and activation of protein kinase A (PKA) after nicotine stimulation of murine inguinal fat cells ([Fig. 2i](#F2){ref-type="fig"}). We further showed that both CREB and p38 were activated in nicotine treated inguinal fat cells ([Fig. 2i](#F2){ref-type="fig"} and [Supplementary Fig. 6a](#SD1){ref-type="supplementary-material"}). Similar activation of the cAMP and PKA pathway was observed in differentiated human subcutaneous adipose cultures stimulated with nicotine ([Fig. 2j](#F2){ref-type="fig"}), and this activation could be blocked by the PKA inhibitor H-89 in both murine inguinal and human subcutaneous fat cultures ([Supplementary Fig. 6b](#SD1){ref-type="supplementary-material"}). This signal was dependent on CHRNA2 with no significant compensation from other nAChR family proteins since no activation of PKA, CREB or p38 was observed in nicotine-treated *Chrna2* KO inguinal fat cells ([Supplementary Fig. 6c, d](#SD1){ref-type="supplementary-material"}). Similarly, the thermogenic marker *Ucp1* was not induced by nicotine stimulation in the absence of *Chrna2* ([Supplementary Fig. 6e](#SD1){ref-type="supplementary-material"}).

Immune cells in subcutaneous fat produce acetylcholine {#S5}
------------------------------------------------------

To investigate whether the activation of CHRNA2 in subcutaneous fat is mediated by locally produced acetylcholine via paracrine/autocrine mechanisms, we analyzed GFP+ cells within the inguinal adipose tissue from ChAT^BAC^-eGFP mice^[@R24]^, which express enhanced green fluorescent protein (eGFP) under the control of the transcriptional regulatory element for Choline acetyltransferase (ChAT), the rate limiting enzyme that mediates the biosynthesis of acetylcholine *in vivo* ([Fig. 3a](#F3){ref-type="fig"}). qPCR and immunohistochemistry analysis revealed that GFP+ cells are indeed present in the inguinal adipose tissue, and consist of a subset of stromal vascular fraction (SVF) cells ([Fig. 3b](#F3){ref-type="fig"} and [Supplementary Fig. 7a](#SD1){ref-type="supplementary-material"}). Enrichment of ChAT protein in inguinal SVF cells was further confirmed by flow cytometric analysis ([Fig. 3c](#F3){ref-type="fig"}). The secretion of acetylcholine from the SVF was directly assayed and validated with mass spectrometry ([Fig. 3d](#F3){ref-type="fig"}). We hypothesized that the local production of acetylcholine from ChAT expressing cells within the subcutaneous fat tissue may closely correlate with the induction of its receptor, namely CHRNA2, in activated beige adipocytes. Indeed both acetylcholine secretion and ChAT expression were higher in the SVF from cold exposed mice compared to those from mice housed at the ambient temperature ([Fig. 3e](#F3){ref-type="fig"}). Conversely, ChAT expression in the SVF was lower in obese mice compared that of lean mice ([Supplementary Fig. 7b](#SD1){ref-type="supplementary-material"}). In order to directly assess the potential role of these acetylcholine-producing SVF cells in regulating the function of neighboring adipocytes, coculture experiments were carried out with a two-chamber transwell system ([Fig. 3f](#F3){ref-type="fig"}). The expression of thermogenic markers was elevated in differentiated inguinal fat cultures that were exposed to freshly isolated SVF compared to control inguinal fat cultures ([Fig. 3f](#F3){ref-type="fig"}) and an additional induction was detected when the coculture was performed in the presence of rivastigmine (inhibitor of acetylcholinesterase and butyrylcholinesterase), which prevents acetylcholine degradation ([Fig. 3f](#F3){ref-type="fig"}), indicating that the effect was at least in part mediated through acetylcholine released from the SVF.

Flow cytometric analysis revealed that about 2.1% of the inguinal SVF of the ChAT^BAC^-eGFP mice were GFP positive, showing significantly higher GFP median fluorescence intensity (MFI) and enriched expression of *Chat* compared to GFP− cells ([Fig. 3g](#F3){ref-type="fig"} and [Supplementary Fig. 7c](#SD1){ref-type="supplementary-material"}). Immune profiling by flow cytometric analysis ([Supplementary Table 1](#SD1){ref-type="supplementary-material"}) revealed that the majority of ChAT-eGFP+ cells were of the CD45+ hematopoietic lineage (98.7±0.2%). Among hematopoietic cells, B220+ B cells made up the largest proportion of immune cell subsets with 44.5±2.5%, followed by CD4+ αβT cells (15.6±1.1%) and M2 macrophages (8.5±0.4%). Of note, there were almost no ChAT-eGFP+ cells that expressed the eosinophil marker Siglec-F ([Fig. 3g](#F3){ref-type="fig"} and [Supplementary Table 1](#SD1){ref-type="supplementary-material"}). It has previously been reported that certain types of B cells or T cells can produce acetylcholine^[@R25],[@R26]^. It is of note that \~ 9% of the total ChAT-eGFP+ cells were characterized as alternatively activated M2 macrophages, which have been implicated to produce catecholamines that activate thermogenic fat cells^[@R27]^. The upregulation of thermogenic gene expression by coculture with SVF was detected even in the absence of β-adrenergic signaling^[@R28]^, indicating that non-catecholamine stimulant(s) exerts this activating effect ([Supplementary Fig. 7d](#SD1){ref-type="supplementary-material"}). This is consistent with recent reports that have challenged the secretion of catecholamine from M2 macrophages^[@R29],[@R30]^.

To investigate the physiological impact of acetylcholine-producing immune cells during beiging, we generated mice in which the *Chat* gene was deleted in CD45+ hematopoietic cells (*Vav-iCre*;*ChAT*^fl/fl^; [Fig. 3h](#F3){ref-type="fig"} and [Supplementary Fig. 8a](#SD1){ref-type="supplementary-material"}). A significant lower *Chat* expression was observed in inguinal white adipose tissue (IWAT) of *Vav-iCre*;*ChAT*^fl/fl^ mice compared to that of control mice, but not in the interscapular brown adipose tissue (BAT), which is consistent with the notion that the ChAT-CHRNA2 axis is beige-selective ([Supplementary Fig. 8b](#SD1){ref-type="supplementary-material"}). The phenotype of *Vav-iCre*;*ChAT*^fl/fl^ mice was comparable to littermate *ChAT*^fl/fl^ controls when housed at room temperature ([Supplementary Fig. 8c--g](#SD1){ref-type="supplementary-material"}). However, hematopoietic ablation of *Chat* caused thermogenic defects in IWAT upon acute cold exposure with a significant lower induction in thermogenic marker expression and oxygen consumption rate compared to those of the control mice ([Fig. 3i](#F3){ref-type="fig"}), whereas not in BAT ([Fig. 3j](#F3){ref-type="fig"}). We performed coculture experiments and observed that the induction of thermogenic markers was trending lower (albeit not statistical significant) in the inguinal fat cells cocultured with the SVF from *Vav-iCre*;*ChAT*^fl/fl^ mice compared to that of littermate *ChAT*^fl/fl^ controls ([Supplementary Fig. 8h](#SD1){ref-type="supplementary-material"}). It is worth noting that thermogenic gene expression in IWAT was comparable upon chronic cold exposure between *Vav-iCre*;*ChAT*^fl/fl^ mice and littermate controls ([Supplementary Fig. 8i--o](#SD1){ref-type="supplementary-material"}) suggesting that systemic acetylcholine may compensate for the loss of local acetylcholine production when cold stimulus persists.

Loss of CHRNA2 affects whole-body metabolism {#S6}
--------------------------------------------

Our results so far demonstrate that an acetylcholine-CHRNA2 signaling axis exists within the subcutaneous adipose depot, and immune cells closely regulate beige fat activation, likely through a paracrine mechanism ([Supplementary Fig. 8p and 9](#SD1){ref-type="supplementary-material"}). Low environmental temperature greatly activates beige fat recruitment within the subcutaneous white adipose depot so that organisms have additional thermogenic capacity to maintain core body temperature^[@R9]^. Cold exposure induced *Chrna2* expression in inguinal fat ([Fig. 1d](#F1){ref-type="fig"}), suggesting that adaptation to cold challenges may be mediated through CHRNA2. *Chrna2* KO mice showed no gross abnormality when housed at ambient temperature^[@R31]^ ([Supplementary Fig. 10a--c](#SD1){ref-type="supplementary-material"}). After chronic cold exposure, adipose tissues of WT mice underwent drastic tissue remodeling including reduced tissue mass, which led to the reduction of overall body weight ([Fig. 4a](#F4){ref-type="fig"}). In comparison, *Chrna2* KO mice showed significantly less body weight loss after being housed in the cold chamber ([Fig. 4a](#F4){ref-type="fig"}). Adipose tissue mass of the visceral white fat depot (VWAT, perigonadal depot) was significantly bigger in *Chrna2* KO mice compared to WT following cold exposure. A similar but not statistically significant trend was observed in the inguinal depot, whereas no mass difference in the interscapular BAT was found between the two genotypes ([Fig. 4b](#F4){ref-type="fig"}). Histology and immunohistochemistry analyses revealed that after cold exposure, fewer UCP1+ multilocular adipocytes were present in inguinal fat tissues of *Chrna2* KO mice compared to WT mice, yet no differences in brown fat were observed ([Supplementary Fig. 10d,e](#SD1){ref-type="supplementary-material"}).

Gene expression analyses revealed that cold-induced activation of the thermogenic program was defective in *Chrna2* KO IWAT, including thermogenic markers (*Dio2, Ppargc1a* and *Ucp1*), fatty acid oxidation genes (*Cpt1b, Lcad* and *Mcad)*, lipolytic genes (*Atg, Hsl* and *Mgll)*, the angiogenic gene *Vegfa* and mitochondrial genes (*Atp5b, Cox4, Cox8b, Cytc, Nd1, Ndufv1, Sdha, Sdhb* and *Uqcrc2*) ([Fig. 4c,d](#F4){ref-type="fig"}). Citrate synthase is the initial enzyme of the TCA cycle and its activity often serves as a sensitive marker for mitochondrial function. Mitochondrial DNA content and citrate synthase activity were lower in the inguinal fat tissue of the cold challenged *Chrna2* KO mice compared to WT mice ([Fig. 4e,f](#F4){ref-type="fig"}). In line with these observations, less induction of protein levels of UCP1, the mitochondrial marker COXIV and representative subunits of the respiratory complexes I-V were detected in IWAT of *Chrna2* KO mice after cold exposure compared to WT mice ([Fig. 4g](#F4){ref-type="fig"}). These led to a significant lower level of both basal and uncoupled respiration in IWAT of *Chrna2* KO mice compared with that of WT mice ([Fig. 4h](#F4){ref-type="fig"}). Notably, the impaired adaptive thermogenic capacity caused by *Chrna2* ablation was limited to IWAT. The induction of thermogenic gene expression was not defective in the interscapular BAT from *Chrna2* KO mice after cold exposure compared to WT mice ([Fig. 4i](#F4){ref-type="fig"}). However, the defective inguinal thermogenic capacity did not cause hypothermia under the cold challenge, presumably due to a compensatory induction of skeletal muscle shivering^[@R10],[@R32],[@R33]^ in *Chrna2* KO mice ([Supplementary Fig. 10f--j](#SD1){ref-type="supplementary-material"}).

Since impaired energy expenditure in IWAT is closely associated with the development of obesity^[@R34]^, we examined the physiological acclimation of *Chrna2* KO mice to nutrient overload. *Chrna2* KO mice did not show differences from WT mice during chow diet feeding ([Supplementary Fig. 11a--g](#SD1){ref-type="supplementary-material"}). The mutant mice displayed greater weight gain on a high-fat diet (HFD) with similar food intake ([Fig. 5a](#F5){ref-type="fig"} and [Supplementary Fig. 11h](#SD1){ref-type="supplementary-material"}). This was accompanied by higher fat content as determined by NMR ([Fig. 5b](#F5){ref-type="fig"}), and larger tissue mass in all three major fat depots, IWAT, VWAT, and BAT ([Fig. 5c](#F5){ref-type="fig"}). Analysis of adipocyte size distribution showed that *Chrna2* KO mice have a lower proportion of small adipocytes but a greater proportion of large adipocytes in both IWAT and VWAT compared to WT mice after HFD challenge ([Fig. 5d,e](#F5){ref-type="fig"} and [Supplementary Fig. 11i](#SD1){ref-type="supplementary-material"}). Along with exacerbated weight gain, the fasting blood glucose and serum insulin levels were significantly higher in *Chrna2* KO mice than in controls, indicating that insulin resistance was developed in the absence of *Chrna2* signaling ([Supplementary Fig. 11j,k](#SD1){ref-type="supplementary-material"}). Consistently, the mutant mice had worsened glucose tolerance and insulin sensitivity ([Fig. 5f,g](#F5){ref-type="fig"}). HFD feeding resulted in a lower thermogenic gene expression in the inguinal fat of *Chrna2* KO mice compared to the controls, with a minimal effect in the BAT ([Fig. 5h,i](#F5){ref-type="fig"}), and a lower whole-body energy expenditure in *Chrna2* KO mice ([Supplementary Fig. 11l](#SD1){ref-type="supplementary-material"}). Visceral fat of *Chrna2* KO mice fed on HFD demonstrated significantly higher mRNA levels of macrophage-related inflammatory genes and was worse in oxidative stress through NADPH oxidase activation, compared to those of control mice ([Supplementary Fig. 11i](#SD1){ref-type="supplementary-material"}). However, *Chrna2* ablation did not have a significant impact on the skeletal muscle following HFD feeding. There were no differences in locomotor activities between the two genotypes and the effects of *Chrna2* ablation were minimal in mRNA expression of mitochondrial oxidative phosphorylation-related genes (*Ppargc1a*, *Atp5b*, *Nd1*, *Sdha*, *Sdhb* and *Ndufv1*), known to be affected by HFD challenge in the skeletal muscle^[@R35]^ ([Supplementary Fig. 11m,n](#SD1){ref-type="supplementary-material"}). Collectively, these results suggest that CHRNA2 signaling in beige adipocytes may provide essential protection against HFD-induced obesity and associated metabolic disorders, and that even partial loss of beige fat regulation may lead to serious detrimental consequences in systemic metabolism.

DISCUSSION {#S7}
==========

Understanding the molecular mechanisms and signaling networks that regulate beige fat activation is of fundamental importance towards the goal of inducing it to protect against obesity in humans. We have identified a unique signaling pathway within activated beige adipocytes, which is conserved between mice and humans. The beige-selective pathway is mediated through a novel immune-adipose communication, and this previously unrecognized acetylcholine-dependent CHRNA2 signaling coordinates the integrated thermogenic response in activated beige fat. Lack of CHRNA2 signaling leads to a compromised adaptation to chronic cold challenge, dysregulates whole body metabolism and exacerbates diet-induced obesity. It is well documented that upon the onset of cold challenge, skeletal muscle and classical brown fat play an essential role to counteract hypothermia. Indeed, snap-shot evaluation of whole-body energy expenditure under cold did not reveal statistically significant differences between *Chrna2* KO mice and the controls. It is also worth pointing out that the canonical β-adrenergic regulation of beige fat remains intact within these *Chrna2* mutant mice. It has been reported that mice with deletion of beige adipocyte function are vulnerable to metabolic challenges^[@R34]^. The thermogenic defects after chronic cold exposure and metabolic dysfunction upon HFD observed in *Chrna2* KO mice, a model with only one branch of beige fat regulation missing, not only further confirms the physiological significance of beige adipocytes as an important metabolic regulator but also highlights the essential role of catecholamine-independent, acetylcholine-CHRNA2 signaling in energy metabolism.

It has been well reported that immune cells residing within the adipose tissue niche closely interact with fat cells to mediate local and systemic metabolic homeostasis^[@R36],[@R37]^. The novel signaling described here demonstrated a dynamic interaction between acetylcholine secreted from immune cells and beige fat-specific CHRNA2, and this signaling directly influences organismal fitness upon environmental challenges, such as cold and obesity. Future investigations will reveal if one subpopulation of the ChAT-expressing immune cells within the subcutaneous fat tissue plays a dominant role regulating CHRNA2-conducted beige fat function. The identification of such a subset, (if it exists), will help to incorporate the acetylcholine-beige fat signaling to the previously known signaling network between immune cells and adipocytes and place this newly defined pathway within the interconnected metabolic matrix.

Nicotine, the main component of tobacco, has been implicated in the effects of smoking on body weight, presumably through central regulation on appetite^[@R38]^. It has also been observed that daily injections of nicotine for 6 months led to decreased food intake, weight loss, and induction of UCP1 in white adipose tissue in mice^[@R39]^. The activation of the thermogenic program in WAT could be, at least partially, mediated through cell-autonomous activation of CHRNA2-signaling in beige adipocytes. Meanwhile, it has been reported that changes in nerve activity influence systemic energy balance and promote WAT browning^[@R40],[@R41]^. Therefore, it is also conceivable that chronic exposure of nicotine activates certain types of cholinergic neurons in the central and/or peripheral nervous systems, elevating energy expenditure and increasing UCP1 expression. No statistically significant differences were observed in food intake between *Chrna2* KO and control mice in our studies. Future investigations should reveal whether CHRNA2-mediated central regulation may also affect systemic metabolism.

Our discovery that nicotine activates the thermogenic program in beige adipocytes through CHRNA2 may suggest novel targets through peripheral pathways to circumvent weight gain associated with smoking cessation. Collectively, our findings suggest that the *Chnra2* pathway could present new targets for beige fat activation to curb obesity and its related metabolic diseases in humans.

ONLINE METHODS {#S8}
==============

Reagents {#S9}
--------

Dexamethasone (D4902), insulin (I5500), 3-IsoButyl-1-MethylXanthine (IBMX, I7018), biotin (B4639), D-pantothenic acid hemicalcium salt (P5155), isoproterenol (I6504), CL-316,243 (C5976), norepinephrine (A7257), dibutyryl-cAMP (D0260), triiodothyronine (T5516), acetylcholine chloride (A2661), nicotine (N3876), (1R,2S,5R)-(−)-menthol (M2780-25G-A) and Fura 2-AM (F0888) were acquired from Sigma Aldrich. Rosiglitazone (71740), GW9662 (70785), pioglitazone (71745), rivastigmine (129101-54-8), and H-89 (10010556) were obtained from Cayman chemical. Collagenase D (11088882001), collagenase B (11088831001), and dispase II (04942078001) were purchased from Roche. Recombinant human BMP4 (314-BP-010) was acquired from R&D Systems. All the cell culture media, including DMEM/F12 GlutaMAX (10565-042), DMEM (11995-073) and MesenPRO RS™ Medium (12746-012), and BODIPY 493/503 (4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene; D3922) were purchased from Life Technologies.

Animals {#S10}
-------

All animal studies were conducted according to the protocol reviewed and approved by the University Committee on Use and Care of Animals at the University of Michigan. All mice were housed under 12-h light/12-h dark cycle (6 a.m.--6 p.m.) with a standard rodent chow diet unless otherwise specified. The 129SVE and Balb/c mice were purchased from Taconic Farms Inc. The *Ucp1*-CRE transgenic mice, the Ai14 reporter mice, C57BL/6J, *ob/ob*, ChAT^BAC^-eGFP, *ChAT*^fl/fl^, *Vav-iCre*, B6.SJL and *Chrna2* knockout mice were obtained from the Jackson Laboratory (Stocks \#024670, \#007914, \#000664, \#000632, \#007902, \#016920, \#008610, \#002014 and \#005797 respectively). β-less mice were provided by Brad Lowell (Beth Israel Deaconess Medical Center, Boston). WT mice were treated with either vehicle (0.25% methylcellulose) or 20 mg/kg/d rosiglitazone via oral gavage for 2 weeks. Hematopoietic cell-specific *ChAT*-deleted mice (*Vav-iCre*;*ChAT*^fl/fl^) were generated by crossing *ChAT*^fl/fl^ and *Vav-iCre* mice. Ten to twelve week old *Chrna2* KO mice and either wild type C57BL/6J or littermate WT controls were used in cold exposure and high-fat diet (HFD) studies. Similar results were obtained with either control group. For cold exposure studies, mice were single housed in prechilled cages in a 10 °C environmental chamber for 2 weeks unless otherwise specified. Age-matched WT and *Chrna2* KO mice were single-housed and maintained on either a chow diet or a HFD consisting of 45% of calories from fat (D12451, Research Diets) for 10 weeks to perform the HFD-induced obesity study. Body weight and food intake were measured weekly for 10 weeks. The food intake was determined by subtracting the weight of remaining food from that of provided food for singly housed mice.

Primary cell culture {#S11}
--------------------

The isolation, culture and differentiation of primary SVF from adipose depots were performed as described previously^[@R1]^. Briefly, fat tissues were dissected, minced and digested in collagenase (1.5 U/ml) (collagenase D for inguinal fat, and collagenase B for interscapular brown fat) and dispase II (2.4 U/ml) solution supplemented with 10 mM CaCl~2~ for 15 to 20 min in a 37 °C water bath with agitation. Digested tissues were filtered through a 100 μm cell strainer and centrifuged at 300--500 × *g* for 5 min to pellet cells. The floating mature adipocytes were collected when they were needed for gene expression analyses. The cell pellet was resuspended and passed through a 40 μm cell strainer and centrifuged as above. The cell pellet was resuspended with culture medium (DMEM/F12 GlutaMAX containing 15 % FBS and penicillin/streptomycin) and plated onto a collagen-coated 10 cm cell culture dish. For adipocyte differentiation, confluent cultures of cells were exposed to induction medium (DMEM/F-12 GlutaMAX supplemented with 10% FBS, penicillin/streptomycin, 0.5 μg/ml insulin, 5 μM dexamethasone, 1 μM rosiglitazone and 0.5 mM IBMX). Two days after induction, cells were cultured in maintenance medium containing 10% FBS, penicillin-streptomycin and 0.5 μg/ml insulin until they were ready for analyses.

Human adipose precursor cells from the subcutaneous adipose tissue were acquired from liposuction performed on healthy adults (a gift from Dr. Jeffrey M. Gimble at Tulane University, New Orleans, Louisiana, USA) and human perirenal adipose precursor cells were isolated from donors postmortem (a gift from Dr. William Rainey at the University of Michigan, Ann Arbor, Michigan, USA). All specimens were collected under the protocols reviewed and approved by the Western Institutional Review Board (Puyallup, WA) or the University of Michigan Medical School Institutional Review Board (IRBMED). Cells were cultured in MesenPRO RS™ medium supplemented with penicillin/streptomycin and stimulated to differentiate in DMEM/F12 GlutaMAX supplemented with 10% FBS, dexamethasone (5 μM), insulin (0.5 μg/ml), IBMX (0.5 mM), rosiglitazone (5 μM), biotin (33 μM), pantothenic acid (17 μM), and BMP4 (20 ng/ml) for 3 d. On the fourth day, cells were cultured in maintenance medium (DMEM/F12 GlutaMAX containing 10% FBS, 0.5 μg/ml insulin, 5 μM dexamethasone, 33 μM biotin, and 17 μM pantothenic acid) until they were fully differentiated.

Transcriptional profiling {#S12}
-------------------------

Total RNA was isolated from differentiated inguinal SVF treated with rosiglitazone (1 μM for 4 d) or a vehicle control and used for microarray analysis. Array hybridization and scanning were performed by the Dana-Farber Cancer Institute Core Facility using affymetrix Gene Chip Mouse Genome 430 2.0 arrays according to established methods.

Gene expression analysis {#S13}
------------------------

Total RNA from adipose tissue and cultured cells were extracted using the TRIzol method. For quantitative real-time PCR (qPCR) analysis, an equal amount of RNA was used to synthesize cDNA according to the instruction for M-MLV Reverse Transcriptase (Life Technologies). qPCR reactions were performed in a 384-well format using SYBR Green (Thermo Fisher Scientific). Relative mRNA levels were calculated using the *ΔΔ*C~T~ method and normalized to *Tbp*. The primer sequence information is shown in [Supplementary Table 2](#SD1){ref-type="supplementary-material"}.

Luciferase reporter assay {#S14}
-------------------------

To construct the luciferase reporter with the promoter of the murine *Chrna2* gene, the −1053 to +31 region of mouse *Chrna2* gene was amplified by PCR using mouse genomic DNA. The amplified fragment was digested with *MluI* and *XhoI* and was cloned into the pGL3 basic vector (Promega) upstream of the firefly luciferase-encoding region. HEK293 cells (ATCC, CRL-1573) were plated onto a 12-well plate and transiently transfected using the polyethylenimine (Thermo Fisher Scientific) method with 909 ng of PPARγ, 90.9 ng of the reporter and 10 ng of renilla (internal control) plasmids. Cells were cultured for 48 h before harvest. Luciferase activity was measured by the Dual-Luciferase Assay kit (Promega) according to the manufacturer's recommendations with a SpectraMax L (Molecular Devices) plate reader. Firefly luciferase activity was normalized to renilla luciferase activity.

Chromatin immunoprecipitation (ChIP) assay {#S15}
------------------------------------------

Differentiated primary inguinal preadipocytes were cross-linked with 1% formaldehyde at room temperature for 7 min and lysed with ChIP cell lysis buffer (10 mM Tris-HCl, pH 8.0, 10 mM NaCl, 3 mM MgCl~2~, 0.5% NP-40, protease inhibitor cocktail) and ChIP nuclear lysis buffer (50 mM Tris-HCl, pH 8.0, 5 mM EDTA, 1% SDS, protease inhibitor cocktail). The cell lysates were sonicated to shear the chromatin, and immunoprecipitated with antibodies for PPARγ (\#sc-7196, Santa Cruz) or IgG (\#2729, Cell Signaling). The immunoprecipitants were isolated using protein A agarose beads (Invitrogen), and washed and eluted with 1% SDS in 0.1 M NaHCO~3~. After reverse cross-linking at 65 °C overnight and proteinase K digestion, immunoprecipitated DNA fragments and input DNA were recovered by a PCR purification kit (Qiagen). The purified DNA was used to amplify the PPARγ regulatory element on the mouse *Chrna2* promoter by a PCR reaction. The PCR products were visualized by electrophoresis on an agarose gel containing ethidium bromide under UV light and quantified using ImageJ software. Primers directed at 7 kb upstream of the binding site were used as a negative control.

BODIPY (493/503) staining {#S16}
-------------------------

To stain lipid droplets, differentiated inguinal preadipocytes of *Ucp1*-CRE-RFP mice were fixed in 10% formalin, washed with PBS, and incubated in PBS supplemented with 0.01 mg/mL fluorescent neutral lipid dye, BODIPY 493/503, at 4°C for 30 min in the dark. The cells were washed with PBS and imaged with a fluorescent inverted Leica DMIRB microscope.

Calcium imaging {#S17}
---------------

SVF isolated from mouse inguinal, mouse interscapular brown, human subcutaneous and human perirenal depots were seeded on collagen-coated glass bottom culture dishes (MatTek Corporation) and induced to differentiate. Fully differentiated adipocytes were loaded with 10 μM of Fura 2-AM for 30 min at 37 °C. After 30 min they were washed twice with standard tyrode's solution (135 mM NaCl, 4 mM KCl, 10 mM glucose, 10 mM HEPES, 2 mM CaCl~2~, and 1 mM MgCl~2~, pH 7.4) at room temperature. Calcium imaging was performed on an Olympus BX51WI Axiovert microscope under a 40× objective. Fluorescence images were documented upon sequential excitation with 340 nm followed by 380 nm with a Roper CoolSnap CCD camera. After establishing a baseline 340/380 nm ratio, the CHRNA2 agonist (500 μM nicotine or 100 μM acetylcholine) was perfused onto the cells. Images were processed with MetaFlour software (Olympus). At 0 s, the basal pseudo color of beige adipocytes and white adipocytes are different, (blue versus pink), reflecting that the color in beige fat cells is the combination of calcium sensing fluorescent dye Fura 2-AM and RFP, whereas white fat cells only have the Fura 2-AM.

ShRNA-mediated gene knockdown {#S18}
-----------------------------

Adenovirus-delivered shRNA targeting human *CHRNA2* was generated by cloning designed shRNA into pAdTrack-H1 vector and constructing adenovirus using AdEasy system as described previously^[@R42]^. To make the adenoviral construct encoding *CHRNA2* shRNA, the primers used were as follows: forward, 5′-GATCCCCCGTTCCTAGCTGGAATGATCTTTCAAGAGAAGATCATTCCAGCTAGGAACGTTTTTA-3′; reverse, 5′-AGCTTAAAAACGTTCCTAGCTGGAATGATCT TCTCTTGAAAGATCATTCCAGCTAGGAACGGGG-3′. The generated adenovirus expressing shCHRNA2 also expressed GFP, which allowed us to verify and visually monitor the infection. To knockdown *CHRNA2* in human subcutaneous adipocytes, differentiated human adipose precursor cells were transduced with adenovirus expressing shRNA against *CHRNA2* and further cultured for 3 d. Adenovirus encoding GFP was used as a control.

Cellular cAMP levels {#S19}
--------------------

cAMP was extracted with 0.1 M HCl from differentiated primary preadipocytes and then quantified using a competitive enzyme immunoassay kit according to manufacturer's instructions (Cayman chemical).

Immunoblotting {#S20}
--------------

Total protein from fat tissues and differentiated primary preadipocytes was prepared in ice-cold lysis buffer (50 mM Tris-HCl, pH 7.5, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride) supplemented with a protease inhibitor cocktail (Roche) and phosphatase inhibitors (10 mM NaF, 60 mM β-glycerolphosphate, pH 7.5, 2 mM sodium orthovanadate, 10 mM sodium pyrophosphate). Proteins were subjected to SDS-PAGE, and were then transferred onto polyvinylidene difluoride (PVDF) membranes. The membranes were probed with following antibodies: from Abcam: UCP1 (ab10983), MitoProfile total OXPHOS (ab110413); from Cell Signaling: COXIV (\#4850), phospho-PKA substrate^S/T^ (\#9621), phospho-CREB^S133^ (\#9198), CREB (\#9212), phospho-p38^T180/Y182^ (\#9215), p38 (\#9197) α-tubulin (\#2144), β-actin (\#8457), GAPDH (\#5174), and HSP90 (\#4874). Phosphorylated CREB and p38 normalized to total CREB and p38, respectively, were quantified using ImageJ software.

Immunofluorescence staining {#S21}
---------------------------

Inguinal fat and brain tissues were fixed in formalin (10%) after dissection. After washing with PBS, tissues were dehydrated in 15% sucrose for 2 d and in 30% sucrose for another 3 d. Following embedding in OCT (Sakura), tissues were sectioned at 16--20 μm. The sections were blocked in 2% normal donkey serum, 3% BSA, and 0.2% Triton X-100 in PBS for 1 h and incubated with a rabbit polyclonal GFP antibody (A-6455, Life Technologies) at a 1:400 dilution overnight. Following incubation with an Alexa Fluor 488-conjugated secondary antibody (ab150073, Abcam) for 1 h at room temperature, slides were mounted with ProLong Gold antifade reagent with DAPI (P36935, Thermo Fisher Scientific) and imaged with a LEICA DM2000.

Acetylcholine quantification {#S22}
----------------------------

Inguinal SVF was isolated from C57BL/6J mice as described above and washed with PBS. The SVF was incubated in PBS supplemented with 150 μM rivastigmine for 40 min at room temperature and then centrifuged to collect supernatant containing acetylcholine (Ach) produced from the SVF. Ach was measured using a previously described LC-MS/MS assay for neurotransmitters^[@R43]^. Briefly, d4Ach (C/D/N isotopes, Pointe-Claire, Canada) was added to samples as an internal standard and resulting samples separated by LC using the Thermo Scientific TSQ Quantum LCMS system. Mobile phase A was 10 mM ammonium formate and 0.15% (v/v) formic acid in water. Mobile phase B was acetonitrile. The gradient was: initial, 5% B; 0.1 min, 19% B; 1 min, 26% B; 1.5 min, 75% B; 2.50 min, 100% B; 3.0 min, 100% B; 3.1 min, 5% B; 3.5 min, 5% B; 4.0 min, 0% B. Ach and d4-Ach were measured by MS/MS using the following transitions (m/z) Ach (product: 146, precursor: 87) and d4-Ach (product: 150, precursor: 91). Quantification was made by using ratio of the peak areas of Ach that were divided by the area of the internal standard for Ach (d4Ach) in comparison to calibration curves.

Adipocyte and SVF coculture assay {#S23}
---------------------------------

Adipocytes and SVF were cocultured in a bicompartmental system using Corning Transwell plates (Corning). Isolated inguinal SVF was seeded and differentiated in the lower compartment of Transwell plates as described above. When adipocytes in the lower compartment were fully differentiated, freshly harvested inguinal SVF was introduced in the upper compartment. The cells were cocultured in DMEM/F12 containing 10% FBS, 1% penicillin/streptomycin and 0.5 μg/ml insulin, with a polycarbonate membrane (0.4 μm pores) in between, for 4 h at 37 °C in 5% CO~2~. The adipocytes were then collected from the lower compartment to analyze gene expression by qPCR.

Flow cytometric analysis {#S24}
------------------------

Isolated SVF from inguinal tissues was blocked in a mixture of normal rat and mouse serum on ice for 15 min and incubated with the following antibodies for immune profiling: CD45 (30-F11, BioLegend), F4/80 (BM8, BioLegend), CD11b (M1/70, Biolegend), MHC Class II (M5/114.15.2, BioLegend), Siglec-F (E50-2440, BD Biosciences), CD11c (N418, BioLegend), CD206 (MR5D3, BioLegend), CD3 (17A2, BioLegend; 17A2, BioLegend), TCRγδ (UC7-13D5, BioLegend), TCRβ (H57-597, BioLegend), CD4 (GK1.5, BioLegend), CD8 (53-6.7, BioLegend), CD19 (1D3/CD19, BioLegend) and B220 (Ra3-6B2, BioLegend). Dead cells were initially excluded based on DAPI (4,6-diamidino-2-phenylindole) uptake and then debris were eliminated using side scatter (SSC)-area (A) vs. forward scatter (FSC)-A. Inguinal SVF of WT mice served as a negative control to identify the ChAT-eGFP+ cell population. The ChAT-eGFP+ cells were gated on hematopoietic lineage (CD45) and subsequently myeloid cells (F4/80 and CD11b). Singlets were separately selected from ChAT-eGFP+ myeloid cells (CD45+, F4/80+, CD11b+) and ChAT-eGFP+ non-myeloid cells (CD45+, F4/80-, CD11b-) using SSC-A vs. SSC-width (not shown) to identify eosinophil/macrophage subsets (Siglec-F, eosinophil; MHC Class II, pan-macrophages; CD11c, M1; CD206, M2) and lymphocyte subsets (CD3, TCRγδ, TCRβ, CD4 and CD8α, T cells; CD19 and B220, B cells), respectively. For intracellular analysis of ChAT expression, the SVF was fixed and permeabilized using BD Cytofix/Cytoperm kit (BD Biosciences) and then incubated with a rabbit monoclonal ChAT antibody (ab181023, Abcam) or isotype IgG control followed by BV421-conjugated anti-rabbit secondary antibody (BioLegend). Dead cells were excluded using Zombie Aqua Fixable Viability kit (BioLegend). Flow cytometry acquisition was performed on a 3-laser Fortessa flow cytometer (Becton Dickinson) and data were analyzed with FlowJo software (TreeStar).

Bone marrow transplantation {#S25}
---------------------------

Bone marrow cells (1×10^6^) from adult *Chrna2* KO and littermate WT control mice (CD45.2) were transplanted into lethally irradiated (2 × 550 cGy, 4 hours apart) recipient B6.SJL mice (CD45.1). After 6 weeks to allow for full reconstitution by the transplanted bone marrow, we confirmed that myeloid and B cells showed a complete turnover in both WT and *Chrna2* KO bone marrow transplant (BMT) recipients mice^[@R44]^.

Histology {#S26}
---------

Adipose tissues were dissected, and fixed in 10% formalin overnight at 4 °C. Paraffin embedding and Hematoxylin & Eosin staining were performed by the University of Michigan Comprehensive Cancer Center Research Histology & Immunoperoxidase Laboratory. Adipocyte size was analyzed with images of H&E sections of WT and *Chrna2* KO IWAT and VWAT (3 mice per genotype), using ImageJ software (Adiposoft^[@R45]^).

Respiration {#S27}
-----------

Freshly isolated inguinal tissues were weighed and minced in respiration buffer (2.5 mM glucose, 50 μM palmitoryl-L-carnitine hydrochloride, 2.5 mM malate, 120 mM NaCl, 4.5 mM KCl, 0.7 mM Na~2~HPO~4~, 1.5 mM NaH~2~PO~4~, 0.5 mM MgCl~2~, pH 7.4). Tissue oxygen consumption in the respiration buffer was recorded for 1--2 min at each stage (basal or uncoupled) using a Clark electrode (Strathkelvin Instruments). 4 mg/ml oligomycin (Sigma) was acutely added to the respiration chamber to measure the uncoupled respiration.

Mitochondrial DNA copy number analysis {#S28}
--------------------------------------

Total DNA was isolated from mouse inguinal fat tissue using Tri-reagent (Sigma) according to the manufacturer's instructions. To estimate mitochondrial DNA copy number, the relative amounts of nuclear and mitochondrial DNA were determined by qPCR with primers specific to the *CoxI* region of the mitochondrial genome and *Rip140* as a nuclear marker gene.

Citrate synthase activity {#S29}
-------------------------

Inguinal tissues were homogenized in extraction buffer (50 mM Tris-HCl, 1 mM MgCl~2~, 100 mM KCl, 250 mM sucrose and 30 mM 2-mercaptoethanol) and centrifuged at 1,000 × *g* for 15 min at 4 °C. Citrate synthase activity in the supernatant was measured with a citrate synthase activity assay kit according to manufacturer's instructions (Cayman chemical).

Immunohistochemistry {#S30}
--------------------

Excised inguinal and brown adipose tissues were fixed in 10% formalin for 24 h, and then were embedded in paraffin and sectioned at 5 μm by the University of Michigan Comprehensive Cancer Center Research Histology & Immunoperoxidase Laboratory. Sections were deparaffinized in xylene, rehydrated in ethanol and distilled water, and then microwaved in 10 mM sodium citrate buffer (pH 6.0) for antigen retrieval. Endogenous peroxidase was quenched with hydrogen peroxide in methanol for 30 min. Sections were blocked with 3% BSA for 1 h and incubated with rabbit polyclonal anti-UCP1 antibody (1:200; ab10983, Abcam) in 3% BSA overnight at 4°C. PBS-washed sections were incubated with biotinylated anti-rabbit antibody for 1 h and exposed to 3,3′-diaminobenzidine (DAB, Vector Laboratories) for 2 min to develop the signal. Hematoxylin was used to counterstain sections. The images were visualized and captured randomly from the stained sections using a LEICA DM2000 microscope.

Metabolic phenotyping {#S31}
---------------------

Blood glucose and serum insulin levels of 4 h-fasted mice were measured using OneTouch Ultra Glucometer (Lifescan) and an insulin ELISA kit (Crystal Chem Inc), respectively. For the glucose tolerance test (GTT), overnight-fasted mice were injected intraperitoneally with 1 g/kg glucose. For the insulin tolerance test (ITT), mice were fasted for 4 h and then received an intraperitoneal injection of 0.5 U/kg insulin (Humulin R, Lilly). GTT and ITT were done 9 and 8 weeks after HFD feeding, respectively. Glucose levels were measured in tail blood prior to and at the indicated times following the injection. The area under the curve (AUC) was calculated for the GTT and ITT with Prism 6 (GraphPad Software, Inc.). University of Michigan Animal Phenotyping Core determined the body composition (quantification of fat and lean mass) using nuclear magnetic resonance analysis. Oxygen consumption (VO~2~), carbon dioxide production (VCO~2~) and spontaneous locomotor activity (at *x*-axis and *y*-axis) were monitored for 48 h using a Comprehensive Laboratory Monitoring System (Columbus Instruments) equipped with photo beam sensors in the University of Michigan Animal Phenotyping Core. Energy expenditure was estimated with VO~2~ and VCO~2~^[@R46]^. Body temperature was monitored using a RET-3 mouse rectal probe (World Precision Instruments).

Statistical analyses {#S32}
--------------------

All results are presented as mean ± s.e.m. and graphed using Prism 6. Data are representative of 2--4 independent experiments. Sample sizes are biological replicates and were chosen based on preliminary data or previously published reports. We first performed normality tests using the Shapiro-Wilk test (3 ≤ n ≤ 7) or the D'Agostino--Pearson omnibus test (n ≥ 8). Normally distributed data were further analyzed by parametric tests including a two-tailed Student's *t*-test for two-group comparisons or a one-way analysis of variance (ANOVA) for multiple comparisons involving one independent variable. When groups followed a non-normal distribution, Mann--Whitney U test was used. Data for whole-body energy expenditure in HFD study were analyzed using analysis of covariance (ANCOVA) with body weight as a covariate since body weight was significantly different between WT and *Chrna2* KO mice fed a HFD. *p*\<0.05 was considered to be statistically significant and was noted as \*(*p*\<0.05), \*\*(*p*\<0.01), \*\*\*(*p*\<0.001).

Data availability {#S33}
-----------------

Accession code for the deposited microarray is GSE79031. The data set generated in the current study is available from the corresponding author on reasonable request. Uncropped immunoblot images available in [Supplementary Fig. 12](#SD1){ref-type="supplementary-material"}. A Life Sciences Reporting Summary is available.
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![*Chrna2* is induced in subcutaneous adipocytes of mice and humans during beiging. (**a**) Microarray and qPCR analyses of *Chrna2* and *Ucp1* mRNA expression in differentiated preadipocytes of wild type C57BL/6J (WT) mice with treatment of vehicle control (Ctrl) or 1 μM rosiglitazone (Rosi) for 4 d (n = 3 per group for microarray, n = 4 for Ctrl, n = 3 for Rosi in qPCR). (**b**) qPCR analyses of nicotinic acetylcholine receptor (nAChR) subunit mRNA levels in differentiated inguinal preadipocytes following 1 μM Rosi treatment for 2 d compared with control (n = 4 per group). (**c**) qPCR analyses of *Chrna2* and *Ucp1* mRNA expression in differentiated inguinal preadipocytes stimulated with vehicle (Ctrl), 0.2 μM norepinephrine (NE) for 2 d (n = 4 for Ctrl, 6 for NE), 10 μM isoproterenol (Iso) for 4 h (n = 4 per group), 0.1 μM CL-316,243 (CL) for 24 h (n = 6 for Ctrl, 4 for CL), 500 μM dibutyryl-cAMP (cAMP) for 6 h (n = 6 per group), or 1 μM triiodothyronine (T3) for 20 h (n = 4 per group). (**d**) qPCR analyses of *Chrna2* and *Ucp1* mRNA expression in inguinal adipose tissues of WT mice following cold exposure (CE) at 4°C for 2 d (n = 6 per group; room temperature, RT) (left) or daily oral gavage of vehicle (n = 9) or 20 mg/kg Rosi (n = 17) for 2 weeks (right). (**e**) qPCR analyses of *CHRNA2* and *UCP1* mRNA levels in differentiated human adipose stromal cells (ASC) from the subcutaneous depot exposed to vehicle, 1 μM Rosi for 4 d (n = 6 per group) or 10 μM Iso for 4 h (n = 4 per group). (**f**) qPCR analyses of *Chrna2*, *Ucp1*, and *Pparg* mRNA levels in the presence of 1 μM Rosi during WT inguinal preadipocyte differentiation (n = 3 per group). (**g**) *Chrna2* transcriptional activity analysis using a murine *Chrna2* promoter luciferase reporter construct with a PPARγ expressing vector or an empty vector as the control (n = 4 per group). (**h**) Representative gel image of chromatin immunoprecipitation (ChIP) analysis of PPARγ binding to the *Chrna2* promoter under stimulation with 1 μM Rosi for 4 d in differentiated inguinal preadipocytes (left). Graph shows enrichment relative to input (n = 4 per group) (right). Data are presented as mean ± s.e.m. Data were analyzed by a two-tailed Student's *t*-test (**a--e,g,h**). \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001. N.D., not detected.](nihms943812f1){#F1}

![CHRNA2 signaling is beige adipocyte-selective. (**a**) Schematic of the generation of *Ucp1*-CRE-RFP mice. In differentiated inguinal preadipocytes, only beige adipocytes expressing RFP are visible at 550nm (red arrows), whereas white adipocytes are not (white arrows) (scale bar, 10 μm). (**b**) Intracellular Ca^2+^ rises in response to the CHRNA2 agonist nicotine (Nic, 500 μM) only in RFP+ beige adipocytes (red arrow) but not in white adipocytes (white arrow) within the subcutaneous fat cultures. (n = 6 for white, 7 for beige). Representative images are shown in a pseudo color scale at different time points (0, 15 and 200 s) (scale bar, 10 μm). (**c**) Brown adipocytes of *Ucp1*-CRE-RFP mice do not respond to nicotine stimulation (n = 13) (scale bar, 10 μm). (**d**) Calcium uptake in response to nicotine is absent in the differentiated inguinal preadipocytes from *Chrna2* KO mice (n = 10). (**e**) Locations of the human subcutaneous and perirenal fat biopsy sites used in this study. (**f**, **g**) Differentiated human adipose stromal cells (ASC) isolated from the subcutaneous fat depot (n = 5) (**f**), but not those from the perirenal depot (n = 11) (**g**), mediate calcium uptake upon nicotine stimulation. (**h**) qPCR analyses of thermogenic markers in differentiated inguinal preadipocytes of wild type (WT) mice following treatment with vehicle control (Ctrl) or 2 mM nicotine (Nic) for 8 h (n = 6 for Ctrl, 3 for Nic). (**i**) cAMP levels of differentiated WT inguinal preadipocytes stimulated with 2 mM Nic or 10 μM isoproterenol (Iso) (left) (n = 5 for Ctrl and Nic, 4 for Iso). Immunoblot for phosphorylation of PKA substrate (middle), CREB, and p38 (right) in differentiated inguinal preadipocytes exposed to 2 mM nicotine for the indicated time or 10 μM Iso for 5 min as a positive control. (**j**) cAMP levels in differentiated human ASC from the subcutaneous depot treated with 2 mM nicotine or 10 μM Iso (n = 4 per group) (left). Immunoblots for phosphorylation of PKA substrate (middle), CREB and p38 (right) in differentiated human ASC treated with 2 mM nicotine for the indicated time or 10 μM Iso for 1 h as a positive control. Representative images or blots are shown. Data are presented as mean ± s.e.m. Data were analyzed by a two-tailed Student's *t*-test (**h**) or a one-way ANOVA (**i,j**). \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001. (**b--g**) In some panels, error bars are almost invisible.](nihms943812f2){#F2}

![Acetylcholine-synthesizing cells of hematopoietic origin reside within inguinal subcutaneous fat tissue. (**a**) Schematic of the generation of ChAT^BAC^-eGFP mice. (**b**) qPCR analyses of *Gfp* mRNA levels in the spleen (n = 14), the brain (n = 6) and IWAT (n = 10) of ChAT^BAC^-eGFP mice and IWAT(n = 3) of C57BL/6J (WT) mice (negative control) (left). qPCR analyses of *Chat* mRNA levels in stromal vascular fraction (SVF) and mature adipocytes from IWAT of WT mice (n = 4 per group) (right). (**c**) Representative histograms and median fluorescence intensities (MFI) for ChAT protein expression in inguinal SVF of WT mice (n = 4 per group). (**d**) Quantification of acetylcholine levels secreted from the inguinal SVF of WT mice. PBS incubated with SVF and without SVF were labeled with "+" and "-", respectively (n = 4 per group). (**e**) MFI of ChAT-eGFP in the GFP+ population from inguinal SVF of ChAT^BAC^-eGFP mice housed at room temperature (RT) or 4°C for 4 h (CE). GFP+ cells and their MFI were monitored by flow cytometry (n = 12 per group) (left). Quantification of acetylcholine levels secreted from the inguinal SVF of WT mice housed at RT or CE (n = 3 per group) (right). (**f**) Adipocytes and SVF in a two-chamber coculture system using a bicompartmental Transwell plate (left). qPCR analyses of thermogenic markers in differentiated WT inguinal preadipocytes cocultured with or without freshly isolated inguinal SVF from WT mice for 4 h in the absence (n = 5 per group) or presence (n = 4 per group) of rivastigmine using a two-chamber coculture system (right). (**g**) Immune profiling of ChAT-expressing cells from inguinal SVF of ChAT^BAC^-eGFP mice. Flow cytometric gating strategy for identifying immune cell subsets in ChAT-eGFP+ cells. All immune cell subsets were labeled with numerals i through x and reported as percentages of the parent population (n = 3 per group) (left). The relative frequencies of immune cell subsets (i-x) within ChAT-eGFP+ cell population are summarized and shown as a pie chart (right). (**h**) qPCR analyses of *Chat* mRNA levels in CD45− and CD45+ cell populations collected by FACS from inguinal SVF of *ChAT*^fl/fl^ and *Vav-iCre*;*ChAT*^fl/fl^ mice (n = 4 per group). (**i**) qPCR analyses of thermogenic markers in IWAT of *ChAT*^fl/fl^ and *Vav-iCre*;*ChAT*^fl/fl^ mice exposed at 4°C for 6 h (CE) (n = 24 per group) (left). Oxygen consumption rate (OCR) in freshly isolated inguinal fat tissue from cold exposed *ChAT*^fl/fl^ and *Vav-iCre*;*ChAT*^fl/fl^ mice in the absence (basal) or presence of oligomycin (n = 8 per group) (right). (**j**) qPCR analyses of thermogenic markers in the interscapular BAT from *ChAT*^fl/fl^ and *Vav-iCre*;*ChAT*^fl/fl^ mice following CE (n = 24 per group). Data are presented as mean ± s.e.m. Data were analyzed by a two-tailed Student's *t*-test (**b--f,h--j**) or Mann-Whitney U test (**i**). \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001. N.S., not significant.](nihms943812f3){#F3}

![Loss of *Chrna2* reduces the adaptive thermogenic capacity of inguinal adipose tissue. (**a**) Changes in body weight of wild type (WT) and *Chrna2* KO mice following 2 weeks cold exposure (CE) at 10°C (n = 22 for WT, 25 for KO). (**b**) Inguinal (IWAT), visceral (VWAT), and interscapular brown (BAT) fat mass in WT and *Chrna2* KO mice after CE (n = 22 for WT, 31 for KO). (**c, d**) qPCR analyses of thermogenic genes (**c**) and mitochondrial genes (**d**) in IWAT from WT and *Chrna2* KO mice after CE (n = 16 for WT, 15 for KO). (**e**) mitochondrial DNA content in IWAT of WT and *Chrna2* KO mice following CE (n = 8 per group). (**f**) Citrate synthase activity in IWAT of cold exposed WT and *Chrna2* KO mice (n = 10 per group). (**g**) Immunoblot analyses of UCP1, the mitochondrial marker COXIV and OxPhos components in IWAT of WT and *Chrna2* KO mice after CE. Representative images are shown. (**h**) Oxygen consumption rate (OCR) in freshly isolated inguinal fat tissue from cold exposed WT and *Chrna2* KO mice in the absence (basal) or presence of oligomycin (n = 6 for WT, 7 for KO). (**i**) qPCR analyses of thermogenic markers in the interscapular BAT from WT and *Chrna2* KO mice following 2 weeks CE (n = 16 per group). Data are presented as mean ± s.e.m. Data were analyzed by a two-tailed Student's *t*-test (**a--f,h,i**). \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001. N.S., not significant.](nihms943812f4){#F4}

![Loss of *Chrna2* exacerbates diet-induced obesity. (**a**) Body weights of WT and *Chrna2* KO mice during high-fat diet (HFD) feeding (n = 9 per group). (**b**) Body composition (n = 8 per group) and (**c**) fat mass (n = 9 per group) of WT and *Chrna2* KO mice following 10 weeks on a HFD. (**d, e**) Representative images of H&E stained sections of IWAT, VWAT, and interscapular BAT (**d**, scale bar, 100 μm), and distribution of adipocyte size of IWAT (**e**) from WT and *Chrna2* KO mice fed a HFD. (**f, g**) Intraperitoneal glucose tolerance (**f**, GTT with 1 g/kg glucose: n = 8 per group) and insulin tolerance (**g**, ITT with 0.5 U/kg insulin: n = 9 per group) test in WT and *Chrna2* KO mice. AUC, area under the curve. (**h**, **i**) qPCR analyses of thermogenic gene expression in IWAT (n = 18 per group) (**h**) and BAT (n = 18 for WT, 19 for KO) (**i**) of WT and *Chrna2* KO mice fed a HFD for 10 weeks. Data are presented as mean ± s.e.m. Data were analyzed by a two-tailed Student's *t*-test (**a--c,f-i**) or Mann-Whitney U test (**h,i**). \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001. N.S., not significant.](nihms943812f5){#F5}
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